Top Markets
#1 Helium Helium +45.70%
#2 TENDIES TENDIES +42.44%
#3 Pons Pons +36.20%
#4 UnifAI Network UnifAI Network +19.28%
#5 Seeker Seeker +18.90%
#6 Songbird Songbird +12.44%
#7 OSK OSK +10.10%
#8 Bounce Bounce +9.81%
#9 DAPPOS DAPPOS +9.74%
#10 Lista DAO Lista DAO +8.75%
Coin of the day
Helium Helium
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Hunan Jiudian Pharmaceutical Co., Ltd. Hunan Jiudian Pharmaceutical Co., Ltd.

Hunan Jiudian Pharmaceutical Co., Ltd.

300705
Rangering i aksjer #10549
Hunan Jiudian Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise... Hunan Jiudian Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise that spans the entire value chain from drug discovery and development to manufacturing and commercialization. The company's extensive product line includes medications for treating allergies, infections, and inflammatory conditions, as well as analgesics and gynecological remedies. Their offerings further extend to products for digestive health, both Western chemical drugs and traditional Chinese patent medicines, medical equipment, and Active Pharmaceutical Ingredients (APIs). Additionally, Hunan Jiudian provides contract manufacturing services for various pharmaceutical formulations, such as tablets, capsules, granules, and oral liquid preparations like solutions and syrups. The company is headquartered in Changsha, China.
Aksjekurs
$1.64
Sist synkronisert: 2026-08-28
Markedsverdi
$821.42M
Endring (1 dag)
-1.13%
Endring (1 år)
-36.82%
Land
CN
Handel Hunan Jiudian Pharmaceutical Co., Ltd. (300705)

Kategori

Healthcare
Inntekter for Hunan Jiudian Pharmaceutical Co., Ltd. (300705)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Hunan Jiudian Pharmaceutical Co., Ltd. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Hunan Jiudian Pharmaceutical Co., Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH